Your browser doesn't support javascript.
loading
Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression.
Dogan, Izzet; Aydin, Esra; Khanmammadov, Nijat; Paksoy, Nail; Saip, Pinar; Aydiner, Adnan.
Afiliação
  • Dogan I; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey. dr.izzetdogan@gmail.com.
  • Aydin E; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey.
  • Khanmammadov N; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey.
  • Paksoy N; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey.
  • Saip P; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey.
  • Aydiner A; Department of Medical Oncology, Istanbul University Institute of Oncology, Millet Street/Fatih, Istanbul, 34093, Turkey.
Sci Rep ; 13(1): 8779, 2023 05 31.
Article em En | MEDLINE | ID: mdl-37258548
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2023 Tipo de documento: Article